Seminars in Oncology
Volume 33 , Pages 17-25 , April 2006

Optimizing Gemcitabine Regimens in Ovarian Cancer

  • Sergio Pecorelli

      Affiliations

    • Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Brescia, Italy
    • Prof Pecorelli served as member of the Eli Lilly International Scientific Advisory Board in September 2005.
    • Corresponding Author InformationAddress reprint requests to Prof Sergio Pecorelli, 2nd Division of Obstetrics and Gynecology, University of Brescia, Pz.le Spedali Civili no. 1, I-25123 Brescia, Italy.
    • ,
  • Brunella Pasinetti

      Affiliations

    • Gynecologic Oncology, University of Brescia, Italy.
    • ,
  • Giancarlo Tisi

      Affiliations

    • Gynecologic Oncology, University of Brescia, Italy.
    • ,
  • Franco Odicino

      Affiliations

    • Gynecologic Oncology, University of Brescia, Italy.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0093-7754(06)00121-7

doi: 10.1053/j.seminoncol.2006.03.014

Seminars in Oncology
Volume 33 , Pages 17-25 , April 2006

Article Tools

* Image Usage & Resolution